Welcome to ProbeChem!Global Supplier of Chemical Probes, Inhibitors & Agonists.
EN | CN

You are here:Home-Chemical Inhibitors & Agonists-Others-Other Targets-OAC2
OAC2

Chemical Structure : OAC2

CAS No.: 6019-39-2

OAC2 (Oct4-activating compound 2)

Catalog No.: PC-43282Not For Human Use, Lab Use Only.

Oct4-activating compound 2 (OAC2) is a small molecule Oct4-activating compound, enhances the iPSC reprogramming efficiency and accelerates the reprogramming process.

Packing Price Stock Quantity
25 mg $118 In stock
50 mg $188 In stock
100 mg $328 In stock
250 mg Get quote

Bulk size, bulk discount!

E-mail: sales@probechem.com

Tech Support: tech@probechem.com

Purity & Documentation Purity: >98% (HPLC) Select Batch:

Biological Activity

Oct4-activating compound 2 (OAC2) is a small molecule Oct4-activating compound, enhances the iPSC reprogramming efficiency and accelerates the reprogramming process.
OAC2 activates Oct4 and Nanog promoter-driven reporters in triplicate luciferase reporter assays, activates endogenous Oct4, Nanog, Sox2, and Tet1 expression.
OAC2 enhances reprogramming about fourfold at day 8 at 1 uM in iSF1 for the generation of mouse iPSCs.

Physicochemical Properties

M.Wt 236.2686
Formula C15H12N2O
Appearance Solid
CAS No.
Storage
Solide Powder
-20 °C 12 Months; 4°C 6 Months
In Solvent
-80 °C 6 Months; -20°C 6 Months
Shipping
Solubility

DMSO: ≥ 2.4 mg/mL

Chemical Name/SMILES

Benzamide, N-1H-indol-5-yl-

References

1. Li W, et al. Proc Natl Acad Sci U S A. 2012 Dec 18;109(51):20853-8.

Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright

Contact Us sales@probechem.com

Bulk Inquiry

* Indicates a Required FieldYour information is safe with us.

  • *Product name:
  • *Applicant name:
  • *Email address:
  • *Organization name:
  • *Requested quantity:
  • *Country:
  • *Additional Information:

Get Quote

* Indicates a Required FieldYour information is safe with us.

  • *Product name:
  • *Applicant name:
  • *Email address:
  • *Organization name:
  • *Requested quantity:
  • *Country:
  • Additional Information: